G
GALAPAGOS DISTILLING CO. S.A.S.
Galapago is a clinical-stage biotechnology company that specializes in the discovery and development of small molecule medicines. This company is headquartered in Belgium.
Country/Area ：Ecuador
Company Email ：magdalena.petkova@glpg.com
Industry ：ElectronicsHealthcarePharmaceuticals
Company address ：l11 a3 Generaal De Wittelaan, Mechelen, Flanders, 2800, Belgium
Company website ：*****
Company phone ：+32 15342900
Established ：1999
Company Revenue ：$22,869,056,000
Number of employees ：1305
SIC Code ：87873
NAICS Code ：32325
Main Products ：Partner with us!STORIES OF PURPOSEGalapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indicationsGalapagos creates new subscription right plansTo the pipeline!Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024Trust and TransparencyIR TeamHealthcare ProfessionalsDisease AreasClinical TrialsStock InformationReflecting on EBMT24 with Judith: A Recap from GlasgowAlliance with GileadEmpowering Patients on Clinical Trials Day and beyondWorking at GalapagosShareholder InformationMake Lupus Visible: Annemarie’s storyInnovation AreasLife at GalapagosWebcasts & Events
Company News
Retail investors invested in Galapagos NV (AMS:GLPG) copped the brunt of last week's €140m market cap decline
Nov 13, 2023
Key Insights Galapagos' significant retail investors ownership suggests that the key decisions are influenced by...
Nov 13, 2023
Landmark Bio Signs Multi-Year Agreement to Manufacture Galapagos' Oncology CAR-T Cell Therapy Clinical Programs at the Point-of-CareNov 6, 2023
Landmark Bio will serve as strategic point-of-care manufacturing partner for Galapagos' CAR-T product candidates in the Boston area WATERTOWN, Mass., Nov. 6, 2023 /PRNewswire/ -- Landmark Bio, a collective endeavor bringing together leaders in industry, academia, and research hospitals to...
Nov 6, 2023Galapagos NV (GLPG) Q3 2023 Earnings Call TranscriptNov 5, 2023
Galapagos NV (NASDAQ:NASDAQ:GLPG) Q3 2023 Earnings Conference Call November 3, 2023 8:00 AM ETCompany ParticipantsSofie Van Gijsel - Head, IRPaul Stoffels -...
Nov 5, 2023Biopharma layoff tracker 2023: Sangamo, Galapagos, Pfizer and more cut staff - PharmaLiveNov 3, 2023
Sangamo Therapeutics is shuttering its Brisbane, California headquarters and cutting its U.S. workforce by approximately 40% of its total headcount.
Nov 3, 2023Web Summary
Q1: What is the address of Galapagos Distilling Co. S.A.S.,
A1: Unfortunately, the provided text does not mention the company's address.
Q2: What products or services does Galapagos Distilling Co. S.A.S. offer?
A2: The provided text does not mention anything related to distillation or spirits. It appears that the company is actually a biotechnology company, as indicated by its involvement in research and development of cell therapies, small molecules, and other pharmaceutical products.
Q3: In which industry is Galapagos Distilling Co. S.A.S. operating?
A3: As mentioned earlier, it seems that this company is not involved in distillation or spirits production. Based on the provided text, it appears to be a biotechnology company, specifically focused on research and development of cell therapies, small molecules, and other pharmaceutical products.
Q4: What services does Galapagos Distilling Co. S.A.S. offer?
A4: As a biotechnology company, Galapagos Distilling Co. S.A.S. likely offers various services related to research and development, such as clinical trials, drug discovery, and manufacturing of pharmaceutical products.
Q5: What is the contact information for Galapagos Distilling Co. S.A.S.?
A5: Unfortunately, the provided text does not mention any contact information for this company.
Q6: When was Galapagos Distilling Co. S.A.S. founded?
A6: The provided text mentions that Galapagos is a biotechnology company that was founded in 1999 as a joint venture between Crucell and Tibotec.
Q7: What is the ticker symbol of Galapagos Distilling Co. S.A.S.?
A7: Unfortunately, the provided text does not mention any ticker symbols for this company.
Q8: In which countries has Galapagos Distilling Co. S.A.S. received marketing authorization for its products?
A8: According to the provided text, Jyseleca (a product of Galapagos) has received marketing authorization in the European Union, Great Britain, and Japan.
A1: Unfortunately, the provided text does not mention the company's address.
Q2: What products or services does Galapagos Distilling Co. S.A.S. offer?
A2: The provided text does not mention anything related to distillation or spirits. It appears that the company is actually a biotechnology company, as indicated by its involvement in research and development of cell therapies, small molecules, and other pharmaceutical products.
Q3: In which industry is Galapagos Distilling Co. S.A.S. operating?
A3: As mentioned earlier, it seems that this company is not involved in distillation or spirits production. Based on the provided text, it appears to be a biotechnology company, specifically focused on research and development of cell therapies, small molecules, and other pharmaceutical products.
Q4: What services does Galapagos Distilling Co. S.A.S. offer?
A4: As a biotechnology company, Galapagos Distilling Co. S.A.S. likely offers various services related to research and development, such as clinical trials, drug discovery, and manufacturing of pharmaceutical products.
Q5: What is the contact information for Galapagos Distilling Co. S.A.S.?
A5: Unfortunately, the provided text does not mention any contact information for this company.
Q6: When was Galapagos Distilling Co. S.A.S. founded?
A6: The provided text mentions that Galapagos is a biotechnology company that was founded in 1999 as a joint venture between Crucell and Tibotec.
Q7: What is the ticker symbol of Galapagos Distilling Co. S.A.S.?
A7: Unfortunately, the provided text does not mention any ticker symbols for this company.
Q8: In which countries has Galapagos Distilling Co. S.A.S. received marketing authorization for its products?
A8: According to the provided text, Jyseleca (a product of Galapagos) has received marketing authorization in the European Union, Great Britain, and Japan.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
